🇺🇸 FDA
Patent

US 10689646

Treatment of genetic disorders associated with DNA repeat instability

granted A61KA61K48/00A61P

Quick answer

US patent 10689646 (Treatment of genetic disorders associated with DNA repeat instability) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN TECHNOLOGIES B.V.
Grant date
Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K48/00, A61P, A61P21/00, A61P25/00